Morning Read: Actelion working on $2.5B deal to acquire ZS Pharma
Actelion is considering a move to acquire ZS Pharma in a deal valued at $2.5 billion.
Actelion is considering a move to acquire ZS Pharma in a deal valued at $2.5 billion.
Medical Specialties Distributors acquired VerbalCare, which developed non verbal comminication tools for hospital patients to help them make their needs known to healthcare professionals through a series of apps.
Cardinal Health purchased a 71 percent stake in naviHealth for $290 million in the first step of its acquisition, which will be integrated into its Medical business.
DaVita HealthCare Partners has acquired dialysis operator Renal Venture for $415 million.
Promus Ventures led the round and its founding partner, Mike Collett, will serve as a board observer on Gauss Surgical's board of directors.
The funding will be used to nearly double PokitDok's ranks from its current level of 40 to 70, particularly for business intelligence, technical and marketing support.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Practo wants to expand its clinical practice management and physician scheduling tools to more cities and countries, and also seeks to add product lines and grow by acquisition.
The funding will be used for sales and marketing support but it will also allocate funds to product development, expanding its platform to include other chronic conditions.
Board Vitals' goal behind the fundraise is to add staff to support an expansion of its customer base and its marketshare.
CEO and founder Dan Rodrigues told TechCrunch it is helping practices cope with the transition to the consumerization of healthcare.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Israeli telemedicine startup TytoCare has developed a handheld diagnostic device to help laypeople collect vital signs and other relevant medical data from patients that physicians can view remotely.
Allergan is the center of attention in a couple of stories this morning with anti-depressant acquisition and a sale of its generics business to Teva.
With a 42.3 percent stake in QuantiaMD, Safeguard Scientifics was the lead investor in the company.
Hometeam likens its software to a matchmaking service "that intelligently matches families with experienced caregivers, connects families to their loved ones through mobile technology..."
CEO and cofounder Samir Malik, said the $1.7 million will be used primarily across product support, sales and marketing.